Therapeutic Windows and Target Concentrations

A therapeutic window is the range of drug exposure that is high enough to be effective but low enough to keep the risk of toxicity acceptable. Within it, a target concentration (or a target exposure index) is the value that dosing aims to achieve. The narrower the window, the more a small change in dose or in a patient's handling of the drug can tip exposure from sub-therapeutic to toxic.

Definition

The therapeutic window is the interval of drug exposure bounded below by the minimum effective concentration and above by the concentration at which the risk of unacceptable toxicity rises; the target concentration is the exposure value within that window toward which dosing is directed.

Scope

This topic defines the therapeutic window, distinguishes it from the related notion of therapeutic index, and explains how a target concentration or exposure metric is chosen and used. It covers why the window is a probabilistic, population-derived band rather than a sharp boundary, and which exposure index (trough, peak, or area under the curve) best predicts effect for different drug types. It is a reference account of concepts, not advice on target values for any patient.

Core questions

• What distinguishes the therapeutic window from the therapeutic index?
• Which exposure measure (peak, trough, or area under the curve) best predicts effect for a given drug?
• Why is a published therapeutic range a population band rather than an individual threshold?
• How is a target concentration translated into a sampling and interpretation strategy?

Key concepts

• Minimum effective concentration
• Minimum toxic concentration
• Therapeutic index
• Population-derived reference range
• Trough, peak, and AUC exposure indices
• Time-dependent versus concentration-dependent effect
• Probabilistic target attainment

Key theories

Concentration-effect (target-concentration) framework

Efficacy and toxicity are treated as functions of concentration, so defining a target concentration band converts the problem of dosing into the problem of achieving and maintaining an exposure that lies within the window predicted to be effective and tolerated.

Mechanisms

Both efficacy and toxicity rise with exposure, but along different concentration-response curves; the gap between the concentration giving adequate effect and the concentration producing unacceptable toxicity defines the window. Which feature of the exposure profile matters depends on the drug's pharmacodynamics: for some agents the peak drives effect, for others the trough or the cumulative area under the concentration-time curve does. Craig's work on antibacterials illustrates how the relevant exposure index (for example peak-to-MIC ratio versus time above a threshold) is identified from the concentration-effect relationship and then becomes the dosing target. Because the curves come from populations, a published range is a band of high average benefit and acceptable average risk, and individual patients may respond outside it.

Clinical relevance

Knowing that a drug has a narrow window and a defined target concentration explains why such drugs are candidates for monitoring and careful dose individualisation. This entry describes how targets are conceived and which exposure metric predicts effect; it is educational and does not state target values or dosing recommendations for any individual.

Evidence & guidelines

The exposure index that best predicts effect is drug-class specific and is derived from concentration-effect studies, as classically demonstrated for antibacterials (Craig, 1998); the underlying target-concentration logic was set out by Holford and Sheiner (1981). Whether targeting a concentration improves outcomes over fixed dosing has been evaluated drug-by-drug rather than in general (Touw et al., 2005).

History

The idea of a band of useful exposure grew out of early dose-response pharmacology and was sharpened once concentrations could be measured routinely in patients. The PK-PD modelling synthesis of the early 1980s formalised the target concentration, and infectious-disease pharmacology in the 1990s clarified that different drugs are best characterised by different exposure indices rather than a single trough value.

Debates

Is a single therapeutic range adequate, or should targets be index-specific?

A trough-based range may not capture the exposure feature that actually drives effect; for many drugs the peak or the area under the curve is more predictive, so reducing the window to one number can mislead.

Key figures

• Nicholas Holford
• Lewis Sheiner
• William Craig
• Malcolm Rowland

Seminal works

• holford-sheiner-1981
• craig-1998

Frequently asked questions

Is the therapeutic window the same as the therapeutic index?

They are related but distinct: the therapeutic window is the range of exposure that is both effective and tolerated, while the therapeutic index is a summary ratio comparing toxic to effective exposure. A drug with a low index has a narrow window.

Why can a patient be within the therapeutic range but still respond poorly?

Published ranges are derived from populations and represent average benefit and risk; individuals vary in sensitivity, so a concentration inside the band does not guarantee response or absence of toxicity for any one person.